<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Knockout dhfr-ts Gene <span id='am-4' about='obo:NCBITaxon_5693' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_47570 obo:NCBITaxon_5653'><span id='am-5' property="rdfs:label" content="Trypanosoma cruzi" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-7'  ></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma cruzi</span> <br /> Generates Attenuated Parasites Able Confer <br /> Protection Virulent Challenge <br /> Cecilia Perez Brandan1*, Angel M. Padilla2, Dan Xu2, Rick L. Tarleton2, Miguel A. Basombrio1 <br /> 1 Instituto Patologia Experimental - CONICET, Universidad Nacional Salta, Salta, <span id='am-75' about='obo:NCBITaxon_260511' typeof='owl:Thing obo:NCBITaxon_33511 obo:NCBITaxon_186623 obo:NCBITaxon_41705 obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_7711 obo:NCBITaxon_1 obo:NCBITaxon_1489388 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_1489341 obo:NCBITaxon_33154 obo:NCBITaxon_7776 obo:NCBITaxon_170194 obo:NCBITaxon_134613 obo:NCBITaxon_7898 obo:NCBITaxon_32443 obo:NCBITaxon_41665 obo:NCBITaxon_2759 obo:NCBITaxon_6072'><span id='am-76' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-77' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:hasRelatedSynonym" content="Argentina Linnaeus, 1758" datatype="xsd:string"></span><span id='am-79' property="rdfs:label" content="Argentina" datatype="xsd:string"></span><span id='am-80'  ></span>Argentina</span>, 2 Center Tropical Emerging Global Diseases, University of <br /> Georgia, Athens, Georgia, United States America <br />  <br />  <br />  <br />      Abstract <br />      Background: <span id='am-9' about='obo:NCBITaxon_5690' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-10' property="rdfs:label" content="Trypanosoma" datatype="xsd:string"></span><span id='am-11'  ></span><span id='am-12' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma</span> cruzi protozoan parasite causes severe disease millions habitants developing <br />      countries. Currently vaccine prevent disease available drugs consequences side <br />      effects. Live vaccines likely effective inducing protection recombinant proteins DNA vaccines; <br />      however, safety problems associated use pointed out. In recent years, increasing knowledge the <br />      molecular genetics Trypanosomes allowed identification elimination genes necessary for <br />      parasite infectivity survival. In sense, targeted deletion disruption specific genes parasite genome may <br />      protect reversion virulent genotypes. <br />  <br />      Methods Findings: By targeted gene disruption generated monoallelic mutant parasites dhfr-ts gene T. <br />      cruzi strain shown naturally attenuated. In comparison T. cruzi wild type epimastigotes, impairment in <br />      growth dhfr-ts+/2 mutant parasites observed mutant clones displayed decreased virulence mice. Also, lower <br />      number T. cruzi-specific CD8+ T cells, comparison induced wild type parasites, detected mice <br />      infected mutant parasites. However, remarkable differences protective effect TCC wild type versus TCC <br />      mutant parasites observed. Mice challenged virulent parasites year original infection mutant <br />      parasites displayed significant control secondary infection. <br />  <br />      Conclusion: <span id='am-55' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-56' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-59'  ></span>This</span> study indicates possible generate genetically attenuated T. cruzi parasites able confer <br />      protection T. cruzi infections. <br />  <br />   Citation: Perez Brandan C, <span id='am-81' about='obo:NCBITaxon_458145' typeof='owl:Thing obo:NCBITaxon_243881 obo:NCBITaxon_243882 obo:NCBITaxon_94015 obo:NCBITaxon_33208 obo:NCBITaxon_94017 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_94020 obo:NCBITaxon_131567 obo:NCBITaxon_74971 obo:NCBITaxon_6854 obo:NCBITaxon_6843 obo:NCBITaxon_33154 obo:NCBITaxon_6905 obo:NCBITaxon_6656 obo:NCBITaxon_1206794 obo:NCBITaxon_153386 obo:NCBITaxon_88770 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6893 obo:NCBITaxon_6072'><span id='am-82' property="rdfs:label" content="Padilla" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-85'  ></span>Padilla</span> AM, Xu D, Tarleton RL, Basombrio MA (2011) Knockout dhfr-ts Gene Trypanosoma cruzi Generates Attenuated Parasites <br />   Able Confer Protection Virulent Challenge. PLoS Negl Trop Dis 5(12): e1418. doi:10.1371/journal.pntd.0001418 <br />   Editor: Ana Rodriguez, New York University School Medicine, United States America <br />   Received June 30, 2011; Accepted October 21, 2011; Published December 13, 2011 <br />   Copyright: &#223; 2011 Perez Brandan et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: This work funded grant PICT 2005 32739 MAB NIH Grant PO1 AI0449790 RLT. The funders role study design, <span id='am-91' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-92' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-95'  ></span>data</span> collection <br />   analysis, decision publish, preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: cecilia.perezbrandan@conicet.gov.ar <br />  <br />  <br />  <br /> Introduction                                                                         unpublished data). The results immunization this <br />                                                                                      attenuated strain promising inoculation live TCC <br />    Chagas disease major health problems Latin                   epimastigotes provided protection infection the <br /> Central America, estimated 7.7 million people                        virulent Tulahuen strain 17 wild isolates <br /> infected [1]. This disease consequence infection                obtained endemic area Chagas Argentina [5]. The <br /> protozoan parasite Trypanosoma cruzi. This flagellate transmitted                 protective capacity naturally attenuated strain also <br /> to mammalian hosts, including humans, feces infected                       evaluated field trials natural vector-derived infection; the <br /> triatomine insects. Infection possible mother fetus                   TCC strain naturally transmitted guinea pigs or <br /> during pregnancy contaminated blood transfusion. So far                       dogs TCC inoculated animals protected against <br /> there effective vaccine Chagas disease current                 secondary natural infections [6&#8211;8]. Unfortunately, potential of <br /> available drugs considerable effects.                                      reversion TCC strain virulent phenotype persistence <br />    Animals surviving infection T. cruzi resistant                       immunocompromised hosts foretold, rendering this <br /> subsequent homologous infections. This resistance exceeds,                      method completely safe broad application domestic <br /> in strength duration, protection achieved various                       reservoirs. <br /> experimental T. cruzi vaccines. Several naturally attenuated strains                    Gene targeting methods provided better understanding <br /> have used immunization-infection assays experimental                      trypanosomatid genetics, allowing introduction removal <br /> models [2,3]. TCC naturally attenuated strain T. cruzi                  specific genes genome organisms. The <br /> was thought unable persistently infect immunocompetent                      generation attenuated parasites unable sustain infection and <br /> mice [4]; however, recent experiments demonstrated                         cause pathology removal virulence metabolic factors <br /> strain does persist experimental animals (Padilla AM,                             reasonable possibility. A range genetically altered <br />  <br />  <br />        www.plosntds.org                                                          1                           December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                            T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br />  <br />   Author Summary                                                              safety device avoid potential reversion virulent <br />                                                                               variants. Moreover, effect mutation evaluated <br />   Chagas disease clinical manifestation infection               dhfr-ts+/2 mutant clones virulent Tulahuen strain. We <br />   produced flagellate parasite Trypanosoma cruzi                   investigated persistence parasites their <br />   currently vaccine prevent disease.                      capacity induce immune response infected hosts and <br />   Therefore, different approaches alternatives urgently                protect subsequent infection. <br />   needed. Vaccination live attenuated parasites has <br />   used effectively mice reduce parasitemia                     Methods <br />   histological damage. However, use live parasites as <br />   inmunogens controversial risk reversion                 Ethics statement <br />   virulent phenotype. In work genetically                             All animal protocols adhered National Institutes of <br />   manipulated naturally attenuated strain T. cruzi                    Health (NIH) &#8216;&#8216;Guide care use laboratory animals&#8217;&#8217; <br />   <span id='am-63' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-64' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="order" datatype="xsd:string"></span>order</span> produce parasites impaired replication                    approved School Health Sciences, National <br />   infectivity, using mutation safety device                  University Salta University Georgia Institutional <br />   reversion virulence. We genetically modified <br />                                                                               Animal Care Use Committee. <br />   parasites display lower proliferation rate vitro and <br />   induced undetectable levels T. cruzi specific <br />   CD8+ T cells injected mice. Furthermore,                        Parasites culture procedures <br />   immune response induced live mutant parasites                         Wild type forms naturally attenuated TCC virulent <br />   confers protection subsequent virulent infection                  Tulahuen strains T. cruzi used, mutant clones <br />   year original immunization.                                derived Tulahuen strain carrying targeted mutation one <br />                                                                               dhfr-ts allele [24]. Epimastigote forms grown 28uC liver <br />                                                                               digested neutralized tryptose medium (LDNT), supplemented with <br /> parasites used experimental vaccines [9,10]                   10% fetal bovine serum (FBS). Metacyclic trypomastigotes either <br /> according literature, T. cruzi knockout lines           obtained stationary phase epimastigote cultures adding 1% <br /> been evaluated experimental immunogens. In approach,                 triatomine gut homogenate [25] epimastigote cultures and <br /> monoallelic mutant clone calmodulin-ubiquitin gene                harvesting parasites 7 10 days. In cases, complement <br /> obtained virulent Tulahuen strain T. cruzi. Mice                  resistant forms purified using normal non decomplemented <br /> inoculated different doses mutant epimastigotes later             serum, quantified hemocytometer used inoculate <br /> challenged virulent wild type Tulahuen trypomastigotes              experimental animals. For challenge experiments, fluorescent CL- <br /> strongly protected, shown reduction parasite burden                tdTomato [26] Tulahuen CL wild type trypomastigotes <br /> [11]. The second approach involved T. cruzi line (L16) carrying           used. These trypomastigote forms obtained from <br /> targeted biallelic deletion lyt-1 gene. Also case, long-       Vero cell monolayers cultures infected mice. Infected Vero <br /> term protection virulent challenge observed mice             cells cultured RPMI 1640 medium 10% FBS humid <br /> pre-inoculated L16 parasites shown reduction                  atmosphere containing 5% CO2 37uC. <br /> parasite load blood [12]. In study, biallelic knockout <br /> of gp72 gene Y T. cruzi strain shown highly                  Generation Trypanosoma cruzi mutant parasites <br /> attenuated able induce long lasting protection                  To generate parasites TCC strain T. cruzi a <br /> subsequent infection virulent T. cruzi [13]. Recently, T. cruzi            disruption dhfr-ts gene, plasmid pBSdh1f8Neo used. <br /> parasites lacking enoyl co-A hydratase genes (ech1+/2 ech22/2)                This plasmid contains coding sequence dhfr-ts gene <br /> were used oral route immunization assays, showing                    interrupted coding sequence neomycin phospho- <br /> vaccination genetically modified T. cruzi parasites confers              transferase gene previously used generation <br /> protection virulent challenge [14].                         single knockout parasites, homologous recombination, the <br />    In case parasitic protozoa, like <span id='am-35' about='obo:NCBITaxon_5820' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-36' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-38' property="rdfs:label" content="Plasmodium" datatype="xsd:string"></span><span id='am-39'  ></span>Plasmodium</span> sp             Tulahuen strain T. cruzi [24]. Transgenic parasites were <br /> Leishmania sp, generation genetically attenuated parasites         generated previously described [24]. A total 107 early-log <br /> use protective vaccines frequently reported                  epimastigotes centrifuged 1,620 g 10 min and <br /> [10,15&#8211;18]. One particular approach generation                     suspended 100 ml Human T Cell NucleofectorTM Solution <br /> <span id='am-20' about='obo:NCBITaxon_5664' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_38581 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-21'  ></span><span id='am-22' property="oboInOwl:hasRelatedSynonym" content="Leishmania tropica major" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) major" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="Leishmania major" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Leishmania major</span> dhfr-ts null mutants. In trypanosomatids dhfr-ts          (Lonza, Cologne) room temperature. The resuspended parasites <br /> a single copy gene codes bifunctional enzyme                    mixed 10 mg DNA total volume 10 ml and <br /> dihydrofolate reductase-thymidylate synthase (DHFR-TS) [19,20].               electroporated using program &#8216;&#8216;U-33&#8217;&#8217; AMAXA <br /> This enzyme catalyzes sequential reactions biosynthesis             Nucleofector Device (Lonza). The electroporated parasites were <br /> dTMP. Therefore inhibition enzyme results thymidine-               cultured 25 cm2 culture flasks 10 ml LDNT medium <br /> less death. Leishmania major parasites completely lacking dhfr-ts         300 mg/ml G418 added 24 h post-transfection. <br /> gene generated gene targeted deletion homolo-                 Individual clones obtained single cell sorting 96-well <br /> gous recombination [21]. As expected, mutant parasites             plate using MoFlow cell sorter (Dako-Cytomation-Denmark). <br /> auxotrophic safety protective potential experi- <br /> mental vaccines evaluated [22]. dhfr-ts2/2 parasites able           Molecular characterization mutant parasites <br /> to persist mice 2 months; however,                         For Southern blot analysis, genomic DNA selected TCC <br /> incapable causing disease susceptible immunode-                clone TCC wild type parasites purified using the <br /> ficient mouse models. A substantial resistance challenge              Phenol-Chloroform method. The DNA digested, <br /> virulent L. major parasites detected [22]. Moreover, heterol-             separated 0.7% agarose gel electrophoresis gels were <br /> ogous protection challenges different Leishmania                 blotted nylon membranes (Hybond-N 0.45-mm-pore-size <br /> <span id='am-60' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-61' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-62' property="rdfs:label" content="species" datatype="xsd:string"></span>species</span> observed [23].                                               filters; Amersham Life Science) using standard methods [27]. For <br />    Here studied biological effect introducing mutation            probes generation, 795 bp DNA segment corresponding to <br /> in dhfr-ts gene naturally attenuated TCC strain T. cruzi        Neomycin Phosphotransferase gene amplified plasmid <br />  <br />  <br />        www.plosntds.org                                                   2                        December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                            T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br /> pBSSK-neo1f8 [28] using primers Neo_for (59 ATGATTGAA-                        epimastigote homogenate antigen. The antibody concentration was <br /> CAAGATGGATT 39) Neo_rev (59 AGAACTCGTCAA-                                 expressed optical density 492-nm wavelength. <br /> GAAGGCGA 39) dhfr-ts gene amplified genomic <br /> DNA TCC wild type parasites using primers DH5_f (59                        Trypanosoma cruzi specific CD8+ T cells determination <br /> TGTCGCTGTTTAAGATCCGC 39) DH6_r (59 CCAT-                                    T. cruzi-infected mice bled blood stained <br /> GAAGATGGCGGTTTAG 39). Labeling probes DNA                          MHC <span id='am-52' about='obo:NCBITaxon_class' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-53' property="rdfs:label" content="class" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>class</span> I tetramer containing T. cruzi specific <br /> hybridization performed according protocol supplied               peptide TSKB20 (TSKB20/Kb-PE tetramer) previously <br /> with PCR-DIG DNA-labeling detection kit (Roche Applied                described [30]. Cells stained anti-CD8&#8211;allophycocya- <br /> Science).                                                                     nin, anti-CD11b&#8211;Cy5-PE, anti-CD4&#8211;Cy5-PE anti-B220&#8211; <br />    PCR analyses carried using template DNA                   Cy5-PE (all Caltag, Burlingame, CA). CD8+ T cells were <br /> TCC wild type TCC dhfr-ts+/2 parasites. The primers                gated CD42 CD11b2 B2202 lymphocyte population. Flow <br /> used PCR analysis specific upstream gene              cytometry carried FACSCalibur flow cytometer <br /> dhfr-ts gene (PG1 59 CTTCGAGGAGCTTTGCTGTT 39                              (Becton Dickinson, San Diego, CA), data analyzed with <br /> PG2 59 GATCCAACCAACTGGAGGAA 39 ) combination                               FlowJo software (Tree Star, Inc., Ashland, OR). <br /> with primer specific neomycin phosphotransferase gene <br /> (N 59 GATCTCCTGTCATCTCACCT 39).                                               Statistical analysis <br />                                                                                 Continuous variables, antibody titers parasite <br /> Epimastigote growth assays                                                    concentrations blood samples, analyzed two-tailed <br />   26105 epimastigotes mutant wild type parasites                Wilcoxon signed-rank test time course plots the <br /> grown 6-wells plates containing 5 ml LDNT medium                    Mann-Whitney Kruskal-Wallis test single-day measure- <br /> well. Samples triplicate number growing               ments. Values expressed mean 6 standard errors the <br /> parasites quantified daily hemocytometer.                            mean separate experiments. Differences <br />                                                                               groups considered significant p,0.05. <br /> Infectivity assays mice <br />    In order evaluate infectivity dhfr-ts+/2 mutant parasites,       Results <br /> different mouse strains used. C57BL/6J (B6) mice were <br /> purchased The Jackson Laboratory. IFNc2/2, Balb/c, Swiss <br />                                                                               Generation TCC dhfr-ts mutant parasites <br />                                                                                  Using constructs targeted interruption dhfr-ts gene, <br /> and nude (nu/nu) mice (1 2 months old) bred and <br />                                                                               single-allele knockout parasites (dhfr-ts+/2) TCC strain T. <br /> maintained animal facility specific pathogen-free <br />                                                                               cruzi easily achieved electroporation plasmid <br /> conditions. Animals inoculated intraperitoneal (i.p.) route <br />                                                                               pBSdh1f8Neo selection 300 mg/ml G418, was <br /> with metacyclic trypomastigote forms mutant wild type <br />                                                                               previously shown Tulahuen strain parasite [24]. The <br /> parasites specified. <br />                                                                               genome locus dhfr-ts gene shown Figure 1A. Southern Blot <br />                                                                               analysis TCC dhfr-ts+/2 clone confirmed correct insertion <br /> Immunization assays                                                           neomycin phosphotransferase gene interrupting coding <br />    To test immunological protection induced mutant clones,             sequence dhfr-ts parasite genome (Figure 1B). By using a <br /> mice inoculated 56105 dhfr-ts+/2 metacyclic                   combination enzymes SalI EcoRI, cut outside the <br /> parasites later challenged, different time points, 104            recombination DNA fragment electroporated using <br /> blood trypomastigotes Tulahuen wild type strain                neomycin phosphotransferase sequence probe, could <br /> 2.56105 culture trypomastigotes derived forms fluorescent              confirm correct interruption target gene, 3 kb <br /> CL-tdTomato strain [26] CL wild type.                                      band obtained expected. When hybridizing dhfr-ts <br />                                                                               probe, bands 2 kb 3 kb obtained, indicating successful <br /> Parasitological determinations                                                interruption dhfr-ts allele. PCR analyses using specifically <br />    Blood (10 ml) drawn tail tip mice slight             designed primers upstream dhfr-ts gene combination with <br /> anesthesia, number parasites 100 fields (parasitemia)          primers neomycin phophotransferase gene revealed <br /> was recorded fresh blood mounts microscope (6400).                 correct insertion antibiotic marker interrupting the <br /> For vivo fluorescence detection, footpads mice subcutaneously           target gene (Figure 1C). However, repeated attempts interrupt <br /> infected CL-tdTomato parasites imaged day               second copy gene create null mutant parasites did <br /> using Maestro2 In Vivo Imaging System (CRi, Woburn, MA)                   succeed, TCC dhfr-ts+/2 Tulahuen dhfr-ts+/2 <br /> with green filter set (acquisition settings: 560 750 10 nm          parasites. Moreover, thymidine addition culture media did <br /> steps; exposure time 88.18 ms 262 binning). Collected images              help obtaining null parasites, suggesting dhfr-ts gene <br /> were unmixed analyzed Maestro software v2.8.0A.                  essential T. cruzi survival vitro. Only occasion <br /> Hemocultures performed seeding, sterile conditions,             attempts, able obtain resistance to <br /> 200 ml heparinized blood 2 ml LIT medium (Liver                    both, neomycin hygromycin, selected parasites still <br /> Infusion Tryptose) supplemented 10% FBS. The cultures               retained copy dhfr-ts gene (data shown). <br /> incubated 28uC analyzed day 15, 30, 45, 60. For PCR <br /> detection T. cruzi, 700 ml blood inoculated animals            Cell growth vitro significantly affected dhfr-ts+/2 <br /> processed following strict PCR decontamination procedures.                    mutant epimastigotes <br /> Sample storage, DNA extraction, amplification using primers                  To determine interruption allele dhfr-ts gene <br /> 121 122 performed previously described [29].                      affects ability T. cruzi replicate culture, dhfr-ts+/2 <br />                                                                               epimastigotes TCC Tulahuen strains, were <br /> Serological determinations                                                    seeded 6-well plates LDNT medium selecting <br />   Total immunoglobulin G antibodies T. cruzi measured            antibiotic pressure parasites counted daily until <br /> by enzyme-linked immunosorbent assay (ELISA) using T. cruzi               stationary phase reached. After day 5, significant impairment <br />  <br />  <br />        www.plosntds.org                                                   3                        December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                           T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br />  <br />  <br /> Figure 1. Disruption allele dhfr-ts gene TCC strain T. cruzi. (A) Diagram expected genomic loci dhfr-ts in <br /> single knockout parasites. (B) Southern Blot analysis genomic DNA wild type dhfr-ts+/2 TCC clone digested combination SalI/EcoRI <br /> enzymes hybridized DNA probe complementary neomycin phosphotransferase gene dhfr-ts gene. (C) PCR analysis using a <br /> combination specific primers complementary coding sequence upstream gene neomycin resistance gene. <br /> doi:10.1371/journal.pntd.0001418.g001 <br />  <br />  <br /> in TCC dhfr-ts+/2 epimastigote growth detected                      animals independently inoculated individual mutant <br /> compared TCC wild type (Figure 2A). However,                        clones Tulahuen wild type parasites control. Nude mice as <br /> differences evident Tulahuen mutant parasites              IFNc2/2 mice infected 56104 Tulahuen dhfr-ts+/2 <br /> compared Tulahuen wild type epimastigotes (Figure 2B).                    parasites succumbed 20&#8211;25 days infection the <br /> Addition thymidine (100 mg/ml) did improve mutant                     parasite load infected mice significantly lower than <br /> parasite growth (data shown).                                            Tulahuen wild type parasites (Figure 3A&#8211;B). In Balb/c <br />                                                                              mouse model differences parasite load mice receiving <br /> In vivo infectivity Tulahuen dhfr-ts+/2 metacyclic                        Tulahuen wild type (26104 metacyclic trypomastigotes/mouse) <br /> trypomastigotes                                                              mutant lines (26105 metacyclic trypomastigotes/mouse) were <br />   Infectivity Tulahuen dhfr-ts+/2 metacyclic trypomastigotes              evident, despite fact 10-fold fewer wild type parasites were <br /> was determined quantifying parasite load blood                    used initiate infections (p,0.05) (Figure 3C). In summary, <br />  <br />  <br />  <br />  <br /> Figure 2. In vitro growth dhfr-ts+/2 wild type epimastigotes. (A) Growth curve TCC wild type versus TCC dhfr-ts+/2 clone (B) <br /> growth curve Tulahuen wild type versus Tulahuen dhfr-ts+/2 clone. These results representative 3 independent experiments. <br /> doi:10.1371/journal.pntd.0001418.g002 <br />  <br />  <br />        www.plosntds.org                                                  4                        December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                           T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br />  <br />  <br /> Figure 3. In vivo infectivity Tulahuen dhfr-ts+/2 Tulahuen wild type metacyclic trypomatigotes. (A) Parasitemia curves IFNc2/2 <br /> mice inoculated 56104 metacyclic trypomastigotes Tulahuen wild type dhfr-ts+/2 parasites. (B) Parasite load nude mice inoculated with <br /> 56104 metacyclic trypomastigotes Tulahuen wild type dhfr-ts+/2 parasites day 20 post-infection. (C) Parasitemia curves Balb/c mice <br /> inoculated 26104 metacyclic trypomastigotes Tulahuen wild type 26105 metacyclic trypomastigotes Tulahuen dhfr-ts+/2 metacyclic <br /> trypomastigotes. Values given means; error bars indicate standard errors means. <br /> doi:10.1371/journal.pntd.0001418.g003 <br />  <br />  <br /> results independent experiments different              mutant compared wild type TCC (Table 1). No mortality was <br /> mouse strains led conclusion parasite load mice           observed animals infected mutant wild type TCC <br /> receiving Tulahuen dhfr-ts+/2 parasites significantly lower         parasites. Thus, natural attenuation TCC leaves narrow <br /> in mice receiving wild type parasites.                                       range measure attenuation mutants. Nevertheless, <br />                                                                              measurable case rates infection obtained TCC <br /> In vivo infectivity TCC dhfr-ts+/2 metacyclic                             dhfr-ts+/2 lower TCC wild type. These results <br /> trypomastigotes                                                              led conclude mutation allele dhfr-ts gene is <br />    To determine naturally attenuated TCC strain              sufficient render mutant parasites virulent their <br /> rendered infective mutation dhfr-ts gene,            parental line. We wondered parasites capable of <br /> evaluated infectivity wild type dhfr-ts mutant TCC lines          surviving long periods time infected hosts; therefore <br /> in different mouse strains. Since TCC parasites naturally display            evaluated persistence TCC dhfr-ts+/2 parasites 60 <br /> undetectable levels direct blood examination immunocom-                120 days post infection. Day 120 samples obtained after <br /> petent infected mice, establishment infection TCC                  immunosupression cyclophosphamide (5 doses 250 mg/kg <br /> mutant parasites determined PCR hemoculture                    cyclophosphamide mouse samples taken 10 days after <br /> blood samples taken day 15 post inoculation. No positive                  dose). On day 60, immunocompetent animals were <br /> hemocultures obtained immunocompetent Balb/c                    negative both, PCR hemoculture, 80% (4/5) nude <br /> Swiss mice injected 56105 TCC dhfr-ts+/2 metacyclic                     mice remained positive. On day 120, 3 surviving immuno- <br /> parasites (Table 1). However, using nude mice infected 105              competent animals (2 Balb/c 1 Swiss) negative PCR <br /> TCC dhfr-ts+/2 metacyclic parasites, parasite recovery hemo-              hemoculture. Parallel determinations TCC wild type <br /> culture demonstrated 3/3 animals infected TCC wild               infected animals did differ TCC dhfr-ts+/2 immuno- <br /> type 4/5 animals infected TCC dhfr-ts+/2 parasites.              competent mice, fact 1 3 animals, a <br /> Lower proportions infected animals detected PCR                positive PCR signal obtained. These results that <br /> immunocompetent Balb/c Swiss mice inoculated                    parasites maintained detectable levels most <br />  <br />  <br />        www.plosntds.org                                                  5                        December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                             T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br />  <br />  Table 1. Infectivity TCC dhfr-ts+/2 TCC wild type                     specific CD8+ T cell profile displayed 22 days infection. The <br />  parasites different mouse strains.                                        percentage parasite-specific CD8+ T cell significant lower in <br />                                                                               mice infected TCC dhfr-ts+/2 parasites compared to <br />                                                                               TCC wild type infected ones (Figure 4B). Only mouse infected <br />  Mouse                                                                        dhfr-ts+/2 displayed defined MHC class I tetramer <br />  strain       Hemoculture                 PCR                                 positive population different naive background levels and <br />               TCC wild       TCC          TCC wild       TCC                  similar TCC wild type infected ones. These results <br />               type           dhfr-ts+/2   type           dhfr-ts+/2           reinforce previous one, demonstrating high attenuation of <br />  Nude         3/3            4/5          ND*            ND* <br />                                                                               TCC dhfr-ts+/2 parasites. <br />  Balb/c       0/3            0/5          2/3            2/5 <br />                                                                               Protective immunity acquired infection TCC wild <br />  Swiss        0/4            0/5          2/4            0/5 <br />                                                                               type dhfr-ts+/2 parasites <br />  *ND: done.                                                                  The TCC strain T. cruzi extensively used our <br />  doi:10.1371/journal.pntd.0001418.t001                                        group live vaccine [7,8,32]. Since TCC dhfr-ts+/2 mutant <br />                                                                               parasites displayed experiments lower infectivity <br /> stringent techniques, opening possibility cases              TCC wild type, tested attenuation would <br /> might completely clear total parasite elimination            affect protective effect TCC virulent challenge. <br /> is difficult assess.                                                       For purpose carried independent short term <br />                                                                               immunization assays. In experiment, groups 4, 30-day- <br /> TCC dhfr-ts+/2 parasites inoculation induces low level                   old C57BL/6 female mice inoculated 56105 <br /> specific CD8+ T cells                                                         metacyclic trypomastigotes TCC wild type, similar forms of <br />    Parasite&#8211;specific CD8+ T cells shown crucial            TCC dhfr-ts+/2 parasites PBS control group. At day 15 <br /> the immunity T. cruzi [31]. It shown wild           post inoculation, animals boosted same <br /> type TCC strain, despite naturally attenuated, able               dose parasites. To determine immunization regimen <br /> induce parasite-specific CD8+ T cells infected mice (Padilla AM,           induced cellular immune response, blood samples taken <br /> unpublished data). Therefore, staining MHC class              immunization phase. In protection assays mice <br /> I tetramer containing T. cruzi specific epitope TSKB20 [30],              immunized TCC dhfr-ts+/2 parasites reached levels of <br /> we able determine generation specific CD8+ T cells             CD8+ T cells specific TSKB20 epitope different the <br /> in peripheral blood mice inoculated TCC dhfr-ts+/2                naive background second boost (Figure 5A). Fifteen <br /> wild type parasites. For purpose C57BL/6J (B6) mice                 days boost, animals challenged 104 <br /> injected 56105 TCC mutant parasites. Blood samples                  metacyclic forms virulent CL strain T. cruzi. <br /> analyzed day 15 post inoculation. As shown Figure 4A, CD8+              Parasitemia measured fresh blood mounts twice week <br /> T cells specific response normal mice infected TCC                animals. Mice previously inoculated TCC wild <br /> wild type parasites, mutant infected mice, level              type TCC dhfr-ts+/2 showed lower parasite load than <br /> CD8+ T cells positive staining MHC class I                   challenged na&#305;&#168;ve mice (Figure 5B). Despite lower number of <br /> tetramer containing TSKB20 tetramer significantly                 specific CD8+ T cells detected mice immunized mutant <br /> different na&#305;&#168;ve mice (Figure 4A). Since attenuation              parasites, differences protection <br /> TCC dhfr-ts+/2 parasites stronger wild type                  conferred wild type dhfr-ts+/2 TCC, suggesting the <br /> parasites analyzed CD8+ response sensible mouse              interruption dhfr-ts allele did affect vaccine- <br /> model. For purpose IFNc2/2 mice inoculated                     induced protection. Similar results obtained another <br /> 56104 metacyclic trypomastigotes mutant wild type TCC                  short term immunization assay Balb/c male mice <br /> parasites. In case, detected differences T. cruzi         immunized doses regimen but <br />  <br />  <br />  <br />  <br /> Figure 4. T. cruzi CD8+ specific response mice infected TCC dhfr-ts+/2 wild type parasites. Frequency TSKB20-specific CD8+ <br /> T cells (A) B6 mice infected 56105 metacyclic parasites mutant wild type TCC parasites (n = 4) (B) IFNc2/2 mice infected 56104 <br /> metacyclic trypomastigotes mutant wild type TCC parasites (n = 6 n = 3 respectively). Bars represent mean frequencies CD8+ <br /> tetramer-positive lymphocytes group; error bars represent standard errors mean. <br /> doi:10.1371/journal.pntd.0001418.g004 <br />  <br />  <br />          www.plosntds.org                                                 6                        December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                           T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br />  <br />  <br /> Figure 5. Short term protection immunocompetent mice infected TCC mutant parasites. (A) Lymphocytes recovered from <br /> blood B6 mice immunized TCC wild type (grey bar) TCC dhfr-ts+/2 (white bar) 14 days boost stained TSKB20 <br /> MHC I tetramer. Bars represent mean frequencies CD8+ tetramer-positive lymphocytes mice group; error bars represent standard <br /> errors mean. (B) Parasitemia curve B6 mice infected 56105 TCC dhfr-ts+/2 metacyclic trypomastigotes, TCC wild type metacyclic <br /> trypomastigotes PBS challenge 104 virulent CL parasites. (C) Dispersion diagrams antibody levels naive animals (non <br /> immunized) immunized 56105 metacyclic trypomastigotes TCC dhfr-ts+/2 TCC wild type. The results expressed ratio of <br /> the absorbance serum sample 490-nm optical density (OD) cutoff value. Dotted lines indicate cutoff adopted positivity, <br /> calculated mean values determined naive controls plus times standard deviation. Positive controls infected with <br /> Tulahuen wild type parasites. (D) Parasitemia curve Balb/c mice infected TCC dhfr-ts+/2 metacyclic trypomastigotes, TCC wild type metacyclic <br /> trypomastigotes PBS challenge 56103 virulent Tulahuen blood trypomastigotes. Values given means; error bars indicate standard <br /> errors mean. <br /> doi:10.1371/journal.pntd.0001418.g005 <br />  <br />  <br /> challenged 56103 blood trypomastigotes virulent                  term immunization assay. For purpose, B6 mice immunized <br /> Tulahuen wild type strain. Specific anti-T. cruzi antibody levels            TCC dhfr-ts+/2 TCC wild type parasites challenge <br /> in sera undetectable mice immunized TCC wild                   370 days post infection virulent parasites. In case, we <br /> type parasites TCC dhfr-ts+/2 (Figure 5C) clearly                     employed approach challenging CL-tdTomato parasites <br /> different level mice infected Tulahuen wild                expressing fluorescent protein td-tomato [26] be <br /> type parasites, determined ELISA 14 days post-boost.                tracked vivo site infection. This technology allows us <br /> This expected previous results group showed               quantitative determination parasite control the <br /> that TCC strain se good inducer humoral                site infection days following challenge. This early <br /> response [33]. However, Balb/c mice pre-infected TCC                    determination important desirable characteristic a <br /> wild type TCC dhfr-ts+/2 metacyclic trypomastigotes showed                vaccine confer rapid response control parasites at <br /> reduced numbers circulating parasites peripheral blood             entry location, limiting proliferation spread through <br /> when compared non immunized control group                             organs. Groups 3, 30-day-old C57BL/6 female mice were <br /> (Figure 5D). Mortality immunized challenged mice                      inoculated 56105 TCC wild type metacyclic <br /> was null animal model. Again, experiment                  trypomastigotes, TCC dhfr-ts+/2 parasites PBS control <br /> differences detected protective capacity dhfr-ts+/2           group. Blood samples taken day 300 post infection order <br /> versus wild type TCC parasites.                                              establish percentage T. cruzi specific CD8+ T cells. At 300 <br />                                                                              days post infection, mouse inoculated TCC dhfr-ts+/2 <br /> dhfr-ts+/2 mutant parasites able confer long lasting                  detectable population CD8+ T cells specific the <br /> protection subsequent T. cruzi virulent infection                  TSKB20 epitope. However, TCC wild type infected mice displayed <br />    To determine duration protection observed short             consistent TSKB20 specific population (Figure 6A). At day 370 <br /> term immunization-challenge experiments, carried long               post-infection, mice challenged footpad with <br />  <br />  <br />        www.plosntds.org                                                  7                        December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                            T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br />  <br />  <br /> Figure 6. Long-term protective immunization TCC dhfr-ts+/2 metacyclic trypomastigotes virulent challenge T. cruzi <br /> CL-tdTomato. A) CD8+ T cells positive TSKB20 day 300 post infection B6 mice inoculated 56105 metacyclic trypomastigotes mutant <br /> and wild type TCC parasites. B) Parasite load challenge, day 370 post infection, 2.56105 bloodstream forms virulent CL-tdTomato <br /> strain. Fluorescence levels measured 13 days. Values given means; error bars indicate standard errors means. <br /> doi:10.1371/journal.pntd.0001418.g006 <br />  <br /> 2.56105 metacyclic trypomastigotes fluorescent CL-                    Overall, attempts create null mutant DHFR-TS <br /> tdTomato strain. Fluorescence site infection                   enzyme strongly suggest dhfr-ts gene essential T. cruzi <br /> measured 13 consecutive days surrogate measurement                  epimastigotes, exogenous thymidine provided. <br /> of parasite load. Figure 6B depicts evolution parasite load              The enzyme dihydrofolate reductase thymidylate synthase T. <br /> during 13 days. Mice previously infected TCC wild type                  cruzi involved number different vital processes, essential <br /> metacyclic trypomastigotes year considerably             parasite survival. The impairment dhfr-ts+/2 epimastigote <br /> protected virulent challenge. Despite displaying               growth agreement depletion allele, the <br /> more attenuated behavior, TCC dhfr-ts+/2 infection produced                enzyme product gene involved synthesis of <br /> similar protective effect compared TCC wild type parasites.               thymidine monophosphate, needed DNA assembly and <br /> Overall, observations indicate both, wild type                therefore, cellular replication. The significant loss ability <br /> dhfr-ts+/2 TCC primo infection conferred long-lasting protec-              Tulahuen dhfr-ts+/2 parasites develop blood parasitism in <br /> tion secondary infections.                                           immunocompetent mice suggests gene considered <br />                                                                              virulence factor T. cruzi. A reduction virulence of <br /> Discussion                                                                   knockout parasites animal models previously observed <br />                                                                              T. cruzi lines. Such case T. cruzi Ynull line, <br />    Targeted gene deletion important                 carrying biallelic targeted deletion gp72 gene. This <br /> tools study gene functions, mainly organisms             mutation impaired ability Y strain parasites maintain a <br /> where current techniques gene silencing RNA                       latent infection immunocompetent mice [13]. Similar results <br /> interference failed [34]. The T. cruzi mutant line carrying        obtained T. cruzi mutants [11,12,50]. Here we <br /> a targeted deletion metabolic gene generated 18                report disruption copy dhfr-ts gene the <br /> years ago [35]. Unfortunately, list genes              naturally attenuated TCC strain T. cruzi results more <br /> altered reverse genetic studies T. cruzi far               attenuated parasites parental strain. <br /> increased considerably [24,35&#8211;49]. In limited experience,               In experimental infections mice T. cruzi virulent <br /> complete deletion identified gene homologous                   parasites strong CD8+ T cell response immunodominant <br /> recombination easy task. The mutants dhfr-ts locus          peptides encoded trans-sialidase <span id='am-1' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="family" datatype="xsd:string"></span>family</span> genes observed [30]. <br /> obtained work attempting delete copies dhfr-ts        However, specific CD8+ T cell response single <br /> gene support notion. Despite correct replacement             epitope (TSKB20) mice infected TCC dhfr-ts+/2 parasites <br /> endogenous dhfr-ts gene different antibiotic resistance genes,        considerably lower mice infected TCC wild type. <br /> presence extra copy genome suggest evasion               The development specific CD8+ T cells determined only <br /> strategy parasite avoid loss essential gene.           kind available antigen. The lower <br /> Apparently, duplications target gene                     proportion T. cruzi specific CD8+ T cells mice infected with <br /> chromosome taking place. Similar events showing target                TCC dhfr-ts+/2 parasites probably correlated the <br /> locus amplification observed trying obtained null               inherent propagation rate previously observed mutant <br /> mutant T. cruzi parasites enoyl-CoA hydratase (ech)              parasites. Therefore, late antigen presentation dendritic cells <br /> UDP-Glcp 49-epimerase (TcGALE) genes [24,38]. Identifying                lower availability parasite antigens capable reaching sites <br /> frequency duplication events place                    priming CD8+ T cell response, taking place. <br /> important targeted deletion protocols probing                However; TCC wild type TCC dhfr-ts+/2 parasites, <br /> plasticity genome intriguing parasite. Possibly,              activated protective immune response second virulent <br /> trisomy polyploidy frequent events expected.               infection. Despite generating lower proportion TSKB20 <br />  <br />  <br />        www.plosntds.org                                                  8                         December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                                                      T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br /> specific CD8+ T cells, dhfr-ts+/2 parasites able induce                                unable transmitted integrated natural <br /> protection immunized mice. This agreement                                    cycle. Even mutant parasites completely cleared the <br /> previous work showing TSKB20 specific CD8+ T cells                                        vaccinated animals, considerable reduction number <br /> contribute optimal control acute infection,                           ability develop insect vector [13] decrease the <br /> crucial development immune resistance [51]. Consid-                                 chances transmitted. Therefore result opens the <br /> ering TSKB20 specific CD8+ T cells account                                        possibility developing genetically modified line increased <br /> approximately 30% total CD8+ T cells C57BL/6                                         safety characteristics naturally attenuated parasites without <br /> infected mice peak response, interesting                       compromising protection induced. Although targeted deletion <br /> TCC dhfr-ts+/2 vaccinated mice protected,                             specific genes conceived potential approach to <br /> display lower proportion TSKB20+CD8+ T cells (compared                                 generate attenuated lines, genetic manipulation complete <br /> TCC wild type infected mice) prior challenge. This suggests                            abrogation infectivity lead loss protective <br /> other cell populations alternative, undefined, epitopes                          immunity. Since immune mechanisms protection T. <br /> may induced vaccination attenuated parasites                               cruzi infection completely understood, debatable if <br /> an important role protection elicited. An alternative non                               case live attenuated vaccines, persistence the <br /> exclusive explanation level CD8+ T cell response                                vaccinating parasites required maintaining protection in <br /> generated maintained immunization, barely                                  long term. Our results support hypothesis highly <br /> detectable efficient crucially curb initial                               controlled acute infection genetically attenuated parasites is <br /> replication challenging parasites resulting lower local                              induce protective response maintained <br /> systemic parasite level. The elucidation mechanisms                              long term conditions vaccinating-parasite <br /> help defining desired characteristics vaccines T.                            persistence detection levels complete clearance. <br /> cruzi infection rational development. <br />    A point worthy mention interruption copy of <br /> the dhfr-ts gene naturally attenuated TCC strain <br />                                                                                                Acknowledgments <br /> seemed render parasites undetectable highly sensitive                              We grateful Ruben Cimino serological determinations. We <br /> methods 60 days post inoculation immunocompetent mice.                                thank Julie Nelson Center Tropical Emerging Global <br /> Parasite recovery low level infections considerably difficult;                           Diseases Flow Cytometry Facility University Georgia. Skillful <br /> thus, dhfr-ts+/2 TCC parasites detected sensitive                                 technical assistance provided Alejandro Uncos, Renato Uncos and <br /> technique previously used demonstrate parasite clearance                                 Federico Ramos. <br /> effective drug treatment [52] suggesting mutant <br /> parasites kept extremely low numbers                                         Author Contributions <br /> significantly affecting protective capacity. This result                             Conceived designed experiments: CPB AMP MAB RLT. <br /> considerable implications genetically modified live                                   Performed experiments: CPB AMP DX. Analyzed data: CPB <br /> attenuated parasites planned used vaccination                                  AMP. Contributed reagents/materials/analysis tools: CPB AMP DX. <br /> animal reservoirs, crucial aspect vaccinating parasites                            Wrote paper: CPB AMP. <br />  <br />  <br /> References <br />  1. WHO/TDR (2007) Epidemiology Chagas&#8217; disease, past present. Report                   13. Basombrio MA, Gomez L, Padilla AM, Ciaccio M, Nozaki T, et al. (2002) <br />     Scientific Working Group Chagas&#8217; disease.                                            Targeted deletion gp72 gene decreases infectivity Trypanosoma cruzi <br />  2. <span id='am-86' about='obo:NCBITaxon_102304' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_6545 obo:NCBITaxon_102300 obo:NCBITaxon_6544 obo:NCBITaxon_102301 obo:NCBITaxon_33154 obo:NCBITaxon_1206795 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072'><span id='am-87' property="rdfs:label" content="Lima" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-90'  ></span>Lima</span> MT, Rondinelli R, Sarno EN, Barcinski MA, Gattas CR (1986)                                mice insect <span id='am-71' about='obo:NCBITaxon_29278' typeof='owl:Thing obo:NCBITaxon_81077 obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-72' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-73' property="rdfs:label" content="vectors" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>vectors</span>. J Parasitol 88: 489&#8211;493. <br />     Preliminary studies infection BALB/c mice clone Trypanosoma            14. Collins MH, Craft JM, Bustamante JM, Tarleton RL (2011) Oral Exposure to <br />     cruzi. Mem Inst Oswaldo Cruz 81: 124.                                                          Trypanosoma cruzi Elicits Systemic CD8+ T Cell Response Protection <br />  3. Rowland EC, Ritter DM (1984) Corpus Christi strain-induced protection                       Heterotopic Challenge. Infect Immun 79: 3397&#8211;3406. <br />     Trypanosoma cruzi infection C3H(He) mice: transfer resistance Brazil strain       15. Mueller AK, Labaied M, Kappe SH, Matuschewski K (2005) Genetically <br />     challenge lymphocytes. J Parasitol 70: 760&#8211;766.                                           modified Plasmodium parasites protective experimental malaria vaccine. <br />  4. Basombrio MA, Besuschio S, Cossio PM (1982) Side effects immunization                       Nature 433: 164&#8211;167. <br />     liver attenuated Trypanosoma cruzi mice rabbits. Infect Immun 36:              16. VanBuskirk KM, O&#8217;Neill MT, De La Vega P, Maier AG, Krzych U, et al. <br />     342&#8211;350.                                                                                       (2009) Preerythrocytic, live-attenuated <span id='am-45' about='obo:NCBITaxon_5833' typeof='obo:NCBITaxon_5820 owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_418107 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-46' property="oboInOwl:hasExactSynonym" content="malaria parasite P. falciparum" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="Plasmodium falciparum" datatype="xsd:string"></span><span id='am-48'  ></span><span id='am-49' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasRelatedSynonym" content="Plasmodium (Laverania) falciparum" datatype="xsd:string"></span>Plasmodium falciparum</span> vaccine candidates <br />  5. Basombr&#305;&#180;o MA, Arredes HR, Rossi R, <span id='am-66' about='obo:NCBITaxon_356573' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_354335 obo:NCBITaxon_131567 obo:NCBITaxon_6820 obo:NCBITaxon_44327 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6821 obo:NCBITaxon_33154 obo:NCBITaxon_72041 obo:NCBITaxon_6681 obo:NCBITaxon_6656 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_88770 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_354340 obo:NCBITaxon_6072'><span id='am-67' property="rdfs:label" content="Molina" datatype="xsd:string"></span><span id='am-68'  ></span><span id='am-69' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Molina</span> Raspi E (1986) Histopath-                        design. Proc Natl Acad Sci U S A 106: 13004&#8211;13009. <br />     ological parasitological evidence immunization mice challenge            17. Vaughan AM, Wang R, Kappe SH (2010) Genetically engineered, attenuated <br />     17 wild isolates Trypanosoma cruzi. Int J Parasitol 16: 375&#8211;380.                       whole-cell vaccine approaches malaria. Hum Vaccin 6. <br />  6. Basombrio MA, Arredes H, Uncos DA, Rossi R, Alvarez E (1987) Field trial                18. Papadopoulou B, Roy G, Breton M, Kundig C, Dumas C, et al. (2002) <br />     vaccination American trypanosomiasis (Chagas&#8217; disease) domestic                     Reduced infectivity <span id='am-14' about='obo:NCBITaxon_5661' typeof='owl:Thing obo:NCBITaxon_38574 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-15' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) donovani" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="Leishmania donovani" datatype="xsd:string"></span><span id='am-18'  ></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Leishmania donovani</span> biopterin transporter genetic <br />     guinea pigs. Am J Trop Med Hyg 37: 57&#8211;62.                                                      mutant use attenuated strain vaccination. Infect Immun 70: <br />  7. Basombrio MA, Nasser JR, Segura MA, Gomez LE (1997) Trypanosoma cruzi:                         62&#8211;68. <br />     effect immunization risk vector-delivered infection guinea pigs.           19. Ivanetich KM, Santi DV (1990) Bifunctional thymidylate synthase-dihydrofolate <br />     J Parasitol 83: 1059&#8211;1062.                                                                     reductase protozoa. FASEB J 4: 1591&#8211;1597. <br />  8. Basombrio MA, Segura MA, Mora MC, Gomez L (1993) Field trial                            20. Ivanetich KM, Santi DV (1990) Thymidylate synthase-dihydrofolate reductase <br />     vaccination American trypanosomiasis (Chagas&#8217; disease) dogs.                        protozoa. Exp Parasitol 70: 367&#8211;371. <br />     Am J Trop Med Hyg 49: 143&#8211;151.                                                             21. Cruz A, Coburn C, Beverley S (1991) Double targeted gene replacement for <br />  9. Jobe O, Lumsden J, Mueller AK, Williams J, Silva-Rivera H, et al. (2007)                       creating null mutants. Proc Natl Acad Sci U S A 88: 7170&#8211;7174. <br />     Genetically attenuated <span id='am-40' about='obo:NCBITaxon_5821' typeof='obo:NCBITaxon_5820 owl:Thing obo:NCBITaxon_418101 obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-41' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-43'  ></span><span id='am-44' property="rdfs:label" content="Plasmodium berghei" datatype="xsd:string"></span>Plasmodium berghei</span> liver stages induce sterile protracted           22. Titus RG, Gueiros-Filho FJ, Freitas LAR, Beverley SM (1995) Development <br />     protection mediated major histocompatibility complex Class I-                       safe live Leishmania vaccine line gene replacement. Proc Nat Acad Sci <br />     dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 196: 599&#8211;607.                  USA 92: 10267&#8211;10271. <br /> 10. Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, et al. (2009) Intracellular            23. Veras P, Brodskyn C, Balestieri F, Freitas L, Ramos A, et al. (1999) A dhfr-ts- <br />     replication-deficient Leishmania donovani induces long lasting protective immunity             Leishmania major knockout mutant cross-protects <span id='am-27' about='obo:NCBITaxon_5659' typeof='owl:Thing obo:NCBITaxon_38582 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-28'  ></span><span id='am-29' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) amazonensis" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasAlternativeId" content="NCBITaxon:31284" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasRelatedSynonym" content="Leishmania mexicana amazonensis" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="Leishmania amazonensis" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Leishmania amazonensis</span>. <br />     visceral leishmaniasis. J Immunol 183: 1813&#8211;1820.                                      Mem Inst Oswaldo Cruz, 94: 491&#8211;496. <br /> 11. Barrio AB, Van Voorhis WC, Basombrio MA (2007) Trypanosoma cruzi:                          24. Xu D, Perez Brandan CM, Basombrio MA, Tarleton RL (2009) Evaluation of <br />     attenuation virulence protective immunogenicity monoallelic                       high efficiency gene knockout strategies Trypanosoma cruzi. BMC Microbiol 9: <br />     disruption cub gene. Exp Parasitol 117: 382&#8211;389.                                        90. <br /> 12. Zago MP, Barrio AB, Cardozo RM, Duffy T, Schijman AG, et al. (2008)                        25. Isola E, Lammel E, Gonzalez Cappa S (1986) Trypanosoma cruzi: differentiation <br />     Impairment infectivity immunoprotective effect LYT1 null mutant                 interaction epimastigotes <span id='am-96' about='obo:NCBITaxon_30075' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_35567 obo:NCBITaxon_35568 obo:NCBITaxon_33354 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6960 obo:NCBITaxon_7524 obo:NCBITaxon_6072 obo:NCBITaxon_33356 obo:NCBITaxon_70999 obo:NCBITaxon_33208 obo:NCBITaxon_33351 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_27479 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_33349 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33345 obo:NCBITaxon_33347 obo:NCBITaxon_33342 obo:NCBITaxon_50557 obo:NCBITaxon_33343'><span id='am-97'  ></span><span id='am-98' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-99' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-100' property="rdfs:label" content="Triatoma" datatype="xsd:string"></span>Triatoma</span> infestans intestinal homogenate. <br />     Trypanosoma cruzi. Infect Immun 76: 443&#8211;451.                                                   Exp Parasitol 62: 329&#8211;335. <br />  <br />  <br />  <br />         www.plosntds.org                                                                   9                             December 2011 | Volume 5 | Issue 12 | e1418 <br />                                                                                                                                                         T. cruzi dhfr-ts KO Vaccine <br />  <br />  <br /> 26. Canavaci AM, Bustamante JM, Padilla AM, Perez Brandan CM, Simpson LJ,                       40. Wilkinson SR, Taylor MC, Horn D, Kelly JM, Cheeseman I (2007) A <br />     et al. (2010) In vitro vivo high-throughput assays testing anti-              mechanism cross-resistance nifurtimox benznidazole trypanosomes. <br />     Trypanosoma cruzi compounds. PLoS Negl Trop Dis 4: e740.                                        Proc Natl Acad Sci U S A 105: 5022&#8211;5027. <br /> 27. Sambrook J, Russel D (2001) Molecular Cloning. A Laboratory Manual: Cold                    41. Caler E, Vaena Avalos S, Haynes P, Andrews N, Burleigh B (1998) <br />     Spring Harbor Laboratory Press.                                                                 Oligopeptidase B-dependent signaling mediates host cell invasion Trypanosoma <br /> 28. Thomas M, Gonzalez A (1997) A transformation vector stage-specific                          cruzi. EMBO Journal 17: 4975&#8211;4986. <br />     expression heterologous genes Trypanosoma cruzi epimastigotes. Parasitol Res          42. Ajioka J, Swindle J (1996) The calmodulin-ubiquitin (CUB) genes Trypanosoma <br />     83: 151&#8211;156.                                                                                    cruzi essential parasite viability. Mol Biochem Parasitol 78: 217&#8211;225. <br /> 29. Britto C, Cardoso M, Wincker P, Morel C (1993) A simple protocol                    43. Annoura T, Nara T, Makiuchi T, Hashimoto T, Aoki T (2005) The origin of <br />     physical cleavage Trypanosoma cruzi kinetoplast DNA present blood samples                 dihydroorotate dehydrogenase genes kinetoplastids, special reference to <br />     use polymerase chain reaction (PCR)- based diagnosis chronic                      biological significance adaptation anaerobic, parasitic conditions. <br />     Chagas disease. Mem Inst Oswaldo Cruz 88: 171&#8211;172.                                              J Mol Evol 60: 113&#8211;127. <br /> 30. Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, et al. (2006)                   44. Conte I, Labriola C, Cazzulo J, Docampo R, Parodi A (2003) The interplay <br />     CD8+ T-Cell responses Trypanosoma cruzi highly focused strain-variant                 folding-facilitating mechanisms Trypanosoma cruzi endoplasmic <br />     trans-sialidase epitopes. PLoS Pathog 2: e77.                                                   reticulum. Mol Biol Cell 14: 3529&#8211;3540. <br /> 31. Padilla AM, Bustamante JM, Tarleton RL (2009) CD8+ T cells Trypanosoma                   45. Souza FS, Rampazzo Rde C, Manhaes L, Soares MJ, Cavalcanti DP, et al. <br />     cruzi infection. Curr Opin Immunol 21: 385&#8211;390.                                                 (2010) Knockout gene encoding kinetoplast-associated protein 3 <br />                                                                                                     (KAP3) Trypanosoma cruzi: effect kinetoplast organization, cell proliferation <br /> 32. Basombrio MA, Besuschio S (1982) Trypanosoma cruzi culture used vaccine to <br />                                                                                                     differentiation. Mol Biochem Parasitol 172: 90&#8211;98. <br />     prevent chronic Chagas&#8217; disease mice. Infect Immun 36: 351&#8211;356. <br />                                                                                                 46. Souza FS, Rampazzo Rde C, Manhaes L, Soares MJ, Cavalcanti DP, et al. <br /> 33. Basombrio MA, Segura MA, Nasser JR (2002) Relationship long-term <br />                                                                                                     (2010) Knockout gene encoding kinetoplast-associated protein 3 <br />     resistance Trypanosoma cruzi latent infection, examined antibody <br />                                                                                                     (KAP3) Trypanosoma cruzi: effect kinetoplast organization, cell proliferation <br />     production polymerase chain reaction mice. J Parasitol 88: 1107&#8211;1112. <br />                                                                                                     differentiation. Mol Biochem Parasitol 172: 90&#8211;98. <br /> 34. Militello K, Refour P, Comeaux C, Duraisingh M (2008) Antisense RNA                     47. Campos PC, Silva VG, Furtado C, Machado-Silva A, Darocha WD, et al. (2011) <br />     RNAi protozoan parasites: Working hard hardly working? Mol Biochem                        Trypanosoma cruzi MSH2: Functional analyses different parasite strains provide <br />     Parasitol 157: 117&#8211;126.                                                                         evidences role oxidative stress response. Mol Biochem Parasitol 176: <br /> 35. Cooper R, Jesus AR, Cross GA (1993) Deletion immunodominant                            8&#8211;16. <br />     Trypanosoma cruzi surface glycoprotein disrupts flagellum-cell adhesion. J Cell Biol        48. Collins MH, Craft JM, Bustam <br /> </body></html>